What Did This CEO Just Do with Personal Shares of Prophase Labs (NASDAQ: PRPH)?

By Carrie Williams

Today, the CEO & CHAIRMAN of Prophase Labs (NASDAQ: PRPH), Ted William Karkus, sold shares of PRPH for $977K.

This is Karkus’ first Sell trade following 7 Buy transactions.

PRPH’s market cap is $27.22M and the company has a P/E ratio of 2.70. Currently, Prophase Labs has an average volume of 1,621. The company has a one-year high of $2.45 and a one-year low of $1.78.

In the last 30 days, insiders have sold $977K worth of PRPH shares and purchased $600K worth of PRPH shares.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

ProPhase Labs, Inc. engages in the manufacturing, distribution and marketing of homeopathic and health care products. Its products include Cold-EEZE, Tk supplement, natural allergy relief, cold and flu relief and Organix Rx Complete.